Translational medicine communications

Keyphrases

Publications

volume 6, number 1, 2021

Jp C Mbagwu, J O Olajugba, Paula-Peace James-Okoro, Obidike Blessing
Clinical progression of patients with COVID-19 in Lagos State, Nigeria. Translational medicine communications 6 (1) (2021)
Santosh Kesari, Gregory C Kasper, Lev Verkh, Terese C Hammond, Marla L Matal, Jay W Hammerling, Nikolai Tankovich, Adrianus P Lim, Kevin H Zhao, Tiffany Juarez, Roberta E Redfern, Jaya M Gill, Natsuko Nomura, Audrey Hiemer, Annie Heng, Jessica Shoemaker
Mesenchymal stem cells in the treatment of severe COVID-19. Translational medicine communications 6 (1) (2021)
Payam Peymani, Tania Dehesh, Farnaz Aligolighasemabadi, Mohammadamin Sadeghdoust, Katarzyna Kotfis, Mazaher Ahmadi, Parvaneh Mehrbod, Pooya Iranpour, Sanaz Dastghaib, Ahmad Nasimian, Amir Ravandi, Biniam Kidane, Naseer Ahmed, Pawan Sharma, Shahla Shojaei, Kamran Bagheri Lankarani, Andrzej Madej, Nima Rezaei, Tayyebeh Madrakian, Marek J Los, Hagar Ibrahim Labouta, Pooneh Mokarram, Saeid Ghavmi
Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Translational medicine communications 6 (1) (2021)
Srikanth Umakanthan, Sanjum Senthil, Stanley John, Mahesh K Madhavan, Jessica Das, Sonal Patil, Ragunath Rameshwaram, Ananya Cintham, Venkatesh Subramaniam, Madhusudan Yogi, Abhishek Bansal, Sumesh Achutham, Chandini Shekar, Vijay Murthy, Robbin Selvaraj
The protective role of statins in COVID-19 patients: a retrospective observational study. Translational medicine communications 6 (1) (2021)
Yendry Ventura-Carmenate, Fatima Mohammed Alkaabi, Yandy Marx Castillo-Aleman, Carlos Agustin Villegas-Valverde, Yasmine Maher Ahmed, Pierdanilo Sanna, Ayesha Abdulla Almarzooqi, Abeer Abdelrazik, Gina Marcela Torres-Zambrano, Maura Wade-Mateo, David Quesada-Saliba, Loubna Abdel Hadi, Antonio Alfonso Bencomo-Hernandez, Rene Antonio Rivero-Jimenez
Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020. Translational medicine communications 6 (1) (2021)
Hamid Reza Kouhpayeh, Farhad Tabasi, Mohammad Dehvari, Mohammad Naderi, Gholamreza Bahari, Tahereh Khalili, Courtney Clark, Saeid Ghavami, Mohsen Taheri
Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study. Translational medicine communications 6 (1) (2021)
Ahsan Naveed, Deeba Naz, Sajjad Ur Rahman
Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics. Translational medicine communications 6 (1) (2021)
Santosh Kesari, Gregory C Kasper, Lev Verkh, Terese C Hammond, Marla L Matal, Jay W Hammerling, Nikolai Tankovich, Adrianus P Lim, Kevin H Zhao, Tiffany Juarez, Roberta E Redfern, Jaya M Gill, Natsuko Nomura, Audrey Hiemer, Annie Heng, Jessica Shoemaker
Correction to: Mesenchymal stem cells in the treatment of severe COVID-19. Translational medicine communications 6 (1) (2021)
Gerald Dieter Griffin
Does Covera-19 know 'when to hold 'em or 'when to fold 'em? A translational thought experiment. Translational medicine communications 6 (1) (2021)
Kar Muthumani, Ziyang Xu, Moonsup Jeong, Joel N Maslow, Vaniambadi S Kalyanaraman, Alagarsamy Srinivasan
Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing. Translational medicine communications 6 (1) (2021)
Niklas Alexander Döbler, Claus-Christian Carbon
Vaccination against SARS-CoV-2: a human enhancement story. Translational medicine communications 6 (1) (2021)

volume 5, number 1, 2020

Eman A Awadelkareem, Sumaia A Ali
Vaccine design of coronavirus spike (S) glycoprotein in chicken: immunoinformatics and computational approaches. Translational medicine communications 5 (1) (2020)
Mahmood Yaseen Hachim, Ibrahim Y Hachim, Kashif Bin Naeem, Haifa Hannawi, Issa Al Salmi, Suad Hannawi
C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis. Translational medicine communications 5 (1) (2020)
Carla J Goldin, Ramiro Vázquez, Fernando P Polack, Damián Alvarez Paggi
Identifying pathophysiological bases of disease in COVID-19. Translational medicine communications 5 (1) (2020)
William R Hartman, Aaron S Hess, Joseph P Connor
Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest. Translational medicine communications 5 (1) (2020)
Kishalay Paria, Debarati Paul, Trinath Chowdhury, Smritikana Pyne, Ranadhir Chakraborty, Shanti M Mandal
Synergy of melanin and vitamin-D may play a fundamental role in preventing SARS-CoV-2 infections and halt COVID-19 by inactivating furin protease. Translational medicine communications 5 (1) (2020)
James Andrew McCracken, Mohamed Nakeshbandi, Jeffrey Arace, Wayne J Riley, Roopali Sharma
COVID-19 related deaths in an urban academic medical center in Brooklyn - a descriptive case series. Translational medicine communications 5 (1) (2020)
Lorenzo Viola, Emanuele Russo, Marco Benni, Emiliano Gamberini, Alessandro Circelli, Luca Bissoni, Domenico Pietro Santonastaso, Giovanni Scognamiglio, Giuliano Bolondi, Luca Mezzatesta, Vanni Agnoletti
Lung mechanics in type L CoVID-19 pneumonia: a pseudo-normal ARDS. Translational medicine communications 5 (1) (2020)

volume 3, 2018

Ronodeep Mitra, Ju Qiao, Sudharsan Madhavan, Gerard L O'Neil, Bailey Ritchie, Praveen Kulkarni, Srinivas Sridhar, Anne L van de Ven, Erica M Cherry Kemmerling, Craig Ferris, James A Hamilton, Eno Essien Ebong
The comparative effects of high fat diet or disturbed blood flow on glycocalyx integrity and vascular inflammation. Translational medicine communications 3 (2018)

Translational medicine communications

Keyphrases

Publications

volume 9, number 1, 2024

volume 8, number 1, 2023

volume 8, 2023

volume 7, number 1, 2022

volume 6, number 1, 2021

volume 5, number 1, 2020

volume 3, 2018